The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior (Q67513942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

B. D. Kretschmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1346965

16 September 2022

B. Zadow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1346965

16 September 2022

T. L. Volz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1346965

16 September 2022

L. Volz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1346965

16 September 2022

W. J. Schmidt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1346965

16 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1346965

16 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

Journal of neural transmission. General section

14 September 2019

published in

23–35

1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1346965

16 September 2022

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

23-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy.

14 September 2019

cites work

1 reference

12 December 2020

Effects of D-cycloserine and cycloleucine, ligands for the NMDA-associated strychnine-insensitive glycine site, on brain-stimulation reward and spontaneous locomotion

1 reference

12 December 2020

D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes

1 reference

12 December 2020

A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats.

1 reference

12 December 2020

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

1 reference

12 December 2020

Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function.

1 reference

12 December 2020

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward

1 reference

12 December 2020

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus

1 reference

12 December 2020

A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

1 reference

12 December 2020

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

1 reference

12 December 2020

Multiple sites for the regulation of the N-methyl-D-aspartate receptor

1 reference

12 December 2020

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics

1 reference

12 December 2020

Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system

1 reference

12 December 2020

D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats.

1 reference

12 December 2020

The behavioral pharmacology of NMDA receptor antagonists

1 reference

12 December 2020

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

12 December 2020

The effect of NMDA antagonists in the radial arm maze task with an interposed delay.

1 reference

12 December 2020

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

1 reference

12 December 2020

Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors

1 reference

12 December 2020

Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain.

1 reference

12 December 2020

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

12 December 2020

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine

1 reference

12 December 2020

CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity

1 reference

12 December 2020

Evidence of glutamatergic deficiency in schizophrenia

1 reference

12 December 2020

The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

An endogenous ligand of the brain sigma/PCP receptor antagonizes NMDA-induced neurotransmitter release

1 reference

12 December 2020

Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine

1 reference

12 December 2020

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

12 December 2020

Biochemical evidence that glycine allosterically regulates an NMDA receptor-coupled ion channel

1 reference

12 December 2020

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

12 December 2020

3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine

1 reference

12 December 2020

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists

1 reference

12 December 2020

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

1 reference

12 December 2020

Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain.

1 reference

12 December 2020

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

12 December 2020

Role of Catecholamines in the Amphetamine Excitatory Response

1 reference

12 December 2020

Presynaptic dopaminergic modulation of cortical input to the striatum

1 reference

12 December 2020

Glycine modulates [3H]MK-801 binding to the NMDA receptor in rat brain

1 reference

12 December 2020

Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.

1 reference

12 December 2020

Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential

1 reference

12 December 2020

Phencyclidine, dizocilpine, and cerebrocortical neurons

1 reference

12 December 2020

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

12 December 2020

Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites

1 reference

12 December 2020

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01253108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1346965%20AND%20SRC:MED&resulttype=core&format=json